SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Zenity: “The disruption is real, but so is the potential”

Tectonic shifts are forcing venture capital to abandon the traditional model to survive

NSO seeks new trial after $168 million jury verdict in WhatsApp case

Noam Mills faced the world’s best in fencing. Now she’s solving a problem most CFOs ignore

Buzz

Most popular

Daily

Weekly

1

Combat-ready and camera-eyed: The X-Intra drone joins Israel’s arsenal

2

Tenable acquires Sam Altman-backed Apex for over $105 million to boost AI security

3

Guardicore founders raise $32 million for new stealth cyber-AI startup

4

Syte files for court protection after burning through $70 million in funding

5

Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive

Emendo

3 stories about Emendo

AnGes laying off 110 EmendoBio employees three years after $250 million acquisition

20.12.23|Meir Orbach

The Japanese pharma company notified the employees of the Israeli firm that they are being fired and the future of the company's technology is unclear at this point

Rachel Diamant Emendo

“Innovation and groundbreaking innovation is really mind blowing. … That’s what inspires me today.”

Rachel Diamant, chief IP officer & head of pipeline development at Emendo Biotherapeutics joins Michael Matias to discuss biology and innovation

מעבדה רפואה 1 זירת הבריאות

Gene Therapy Company Emendo Biotherapeutics Raises $61 Million

16.01.20|Adi Pick

Emendo uses protein engineering to treat certain genetic disorders and diseases